|
[Related PubMed/MEDLINE]
Total Number of Papers: 7686
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: cAMP |
| Long Form |
: cyclic adenosine monophosphate |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
2D Transition Metal Dichalcogenides Trigger Trained Immunity in Human Macrophages through Epigenetic and Metabolic Pathways. |
TMDs |
| 2 |
2022 |
A junctional cAMP compartment regulates rapid Ca2+ signaling in atrial myocytes. |
--- |
| 3 |
2022 |
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases. |
beta2AR, CF, CFTR, PDE, PI3Kgamma, PI3Kgamma MP, PKA |
| 4 |
2022 |
A three-dimensional finite element model of cAMP signals. |
--- |
| 5 |
2022 |
A Vasopressin-Induced Change in Prostaglandin Receptor Subtype Expression Explains the Differential Effect of PGE2 on AQP2 Expression. |
AQP2, AVP, PGE2 |
| 6 |
2022 |
Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): Role of P2Y12 -cAMP signaling pathway. |
aPL, cGMP, PRP, t-PAPS, t-PAPS, WPs |
| 7 |
2022 |
Anti-Thrombotic Effects of Artesunate through Regulation of cAMP and PI3K/MAPK Pathway on Human Platelets. |
cGMP, VASP |
| 8 |
2022 |
Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway. |
ADP, ELISA, GP, TMP |
| 9 |
2022 |
Application of machine learning to predict the inhibitory activity of organic chemicals on thyroid stimulating hormone receptor. |
AUC, CE, CIE, LR, RF, ROC, TSHR, XGB, XGBR |
| 10 |
2022 |
Blue Whiting (Micromesistius poutassou) Protein Hydrolysates Increase GLP-1 Secretion and Proglucagon Production in STC-1 Cells Whilst Maintaining Caco-2/HT29-MTX Co-Culture Integrity. |
BWSPHs, CCK, GLP-1, IL, PYY, SGID |
| 11 |
2022 |
C-type Natriuretic Peptide-induced PKA Activation Promotes Endochondral Bone Formation in Hypertrophic Chondrocytes. |
cGMP, CNP, FRET, GC, PKA |
| 12 |
2022 |
cAMP-Dependent Synaptic Plasticity at the Hippocampal Mossy Fiber Terminal. |
MF, PKA |
| 13 |
2022 |
Chinese natural compound decreases pacemaking of rabbit cardiac sinoatrial cells by targeting second messenger regulation of f-channels. |
TCM, TMYX |
| 14 |
2022 |
Clinical Analysis of the Renal Protective Effect of GLP-1 on Diabetic Patients Based on Edge Detection. |
AGEs |
| 15 |
2022 |
Clinical Implication of Phosphodiesterase-4-Inhibition. |
PDEI |
| 16 |
2022 |
Comprehensively dissecting the hub regulation of PkaC on high-productivity and pellet macromorphology in citric acid producing Aspergillus niger. |
PKA, WGCNA |
| 17 |
2022 |
Diindolylmethane ameliorates platelet aggregation and thrombosis: In silico, in vitro, and in vivo studies. |
ADP, COX-1, DIM, GPVI, I3C, P2Y12, PGE2, ROS, TTO, TXB2 |
| 18 |
2022 |
Dual regulation of miR-375 and CREM genes in pancreatic beta cells. |
CREM, miR-375 |
| 19 |
2022 |
Effect of phosphodiesterase-4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model. |
IBS, L-NNA, nNOS, NO, NOS, PDE, PDE4, Rp-cAMPS, TTX, WAS |
| 20 |
2022 |
Effects of a Chinese herbal extract on the intestinal tract and aquaporin in Adriamycin-induced nephropathy. |
ADH, AQP, AVP, SPF |
| 21 |
2022 |
Effects of long-term treatment with dietary theobromine on rat skeletal muscles. |
--- |
| 22 |
2022 |
FACI Is a Novel CREB-H-Induced Protein That Inhibits Intestinal Lipid Absorption and Reverses Diet-Induced Obesity. |
Cas9, CRISPR, FACI, HNF4alpha, PGC-1alpha, SREBP1 |
| 23 |
2022 |
Fraxinol Stimulates Melanogenesis in B16F10 Mouse Melanoma Cells through CREB/MITF Signaling. |
--- |
| 24 |
2022 |
Functional characterization of cAMP signaling of variant porcine MC1R alleles in PK15 cells. |
MC1R |
| 25 |
2022 |
Genistein Stimulation of White Adipose Tissue Thermogenesis Is Partially Dependent on GPR30 in Mice. |
WAT |
| 26 |
2022 |
GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation. |
GIPR, GLP-1R |
| 27 |
2022 |
Glucocorticoids rapidly promote YAP phosphorylation via the cAMP-PKA pathway to repress mouse cardiomyocyte proliferative potential. |
CMs, GC, PKA, YAP |
| 28 |
2022 |
Group 3 innate lymphocytes (ILC3s) upregulate IL-22 in response to elevated intracellular cAMP levels. |
Th17 |
| 29 |
2022 |
History-dependent dopamine release increases cAMP levels in most basal amygdala glutamatergic neurons to control learning. |
BA |
| 30 |
2022 |
Human pluripotent stem cell-derived cells endogenously expressing follicle-stimulating hormone receptors: modeling the function of an inactivating receptor mutation. |
FSH, FSHR, IGF1R, WT |
| 31 |
2022 |
Hypoglycemic and Hypolipogenic Action of Acetic Acid and Monascus-Fermented Grain Vinegar: A Comparative Study. |
AMPK, DB, MV |
| 32 |
2022 |
In vitro inhibition of phosphodiesterase type 4 enhances rat corpus cavernosum nerve-mediated relaxation induced by gasotransmitters. |
CC, cGMP, EFS, NO, PDE5 |
| 33 |
2022 |
In Vivo cAMP Dynamics in Drosophila Larval Neurons. |
--- |
| 34 |
2022 |
Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice. |
Cx43, PDE4, PKA, PSNL, TNF-alpha |
| 35 |
2022 |
Integrated Pharmacogenetics Analysis of the Three Fangjis Decoctions for Treating Arrhythmias Based on Molecular Network Patterns. |
cGMP, CR, GLT, HET, IL-6, mRNAs, RAAS, VA, ZT |
| 36 |
2022 |
Kinetic Studies of the Activation of Bordetella pertussis Adenylate Cyclase by Calmodulin. |
AC, ACT, CaM |
| 37 |
2022 |
Light dependent synthesis of a nucleotide second messenger controls the motility of a spirochete bacterium. |
--- |
| 38 |
2022 |
Live Cell Imaging of Cyclic Nucleotides in Human Cardiomyocytes. |
cGMP, FRET |
| 39 |
2022 |
Mechanisms of Lian-Gui-Ning-Xin-Tang in the treatment of arrhythmia: Integrated pharmacology and in vivo pharmacological assessment. |
ADR, AR, KEGG, LGNXT, PKA, TCM |
| 40 |
2022 |
miR-542-3p-Targeted PDE4D Regulates cAMP/PKA Signaling Pathway and Improves Cardiomyocyte Injury. |
p-PKA |
| 41 |
2022 |
Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ. |
alpha-SMA, CFs, CHO, COPD, CTGF, CysLT1R, PTX, TAC, TGF-beta |
| 42 |
2022 |
Neurotoxic Potential of Deoxynivalenol in Murine Brain Cell Lines and Primary Hippocampal Cultures. |
DON, TNF |
| 43 |
2022 |
Novel Opioid Analgesics for the Development of Transdermal Opioid Patches That Possess Morphine-Like Pharmacological Profiles Rather Than Fentanyl: Possible Opioid Switching Alternatives Among Patch Formula. |
DOR, KOR, MOR, OR |
| 44 |
2022 |
Opioid Receptor Expression in Colorectal Cancer: A Nested Matched Case-Control Study. |
GTEx, IHC, OGFr, PKA |
| 45 |
2022 |
Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis. |
Mtb |
| 46 |
2022 |
Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder. |
ASD, cGMP, FXS, PDE2A |
| 47 |
2022 |
Phosphodiesterase 4D promotes angiotensin II-induced hypertension in mice via smooth muscle cell contraction. |
AMPK, Ang II, MYPT1, PDE, SMCs |
| 48 |
2022 |
Quantitative Phosphoproteomics to Study cAMP Signaling. |
PDEs, PKA |
| 49 |
2022 |
Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR. |
CaSR, PTH, WT |
| 50 |
2022 |
Real-Time Measurements of Intracellular cAMP Gradients Using FRET-Based cAMP Nanorulers. |
GPCRs, PDEs |
| 51 |
2022 |
Receptor activity-modifying protein 1 regulates mouse skin fibroblast proliferation via the Gαi3-PKA-CREB-YAP axis. |
CGRP, DOX, G protein, IF, IHC, MSF, PKA, qPCR, RAMP1, YAP |
| 52 |
2022 |
Repercussion of cAMP and EPAC in Memory and Signaling. |
DRG, Epac, EPAC1 and EPAC2, HCN, PKA |
| 53 |
2022 |
Repurposing Probenecid for the Treatment of Heart Failure (Re-Prosper-HF): a study protocol for a randomized placebo-controlled clinical trial. |
HFrEF, Re-Prosper-HF |
| 54 |
2022 |
Shenfu Administration Improves Cardiac Fibrosis in Rats With Myocardial Ischemia-Reperfusion Through Adenosine A2a Receptor Activation. |
A2aR, MI/R, MMP-9, SFI |
| 55 |
2022 |
Sodium ferulate inhibits rat cardiomyocyte hypertrophy induced by Ang II through enhancement of eNOS/NO/cGMP signaling pathway. |
Ang II, cGMP, eNOS, NO, NOS, PKCbeta, SF |
| 56 |
2022 |
Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. |
BDNF, CNS, NDDs |
| 57 |
2022 |
Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis. |
DSS, PDE4, PKA, UC |
| 58 |
2022 |
The Effect and Mechanism of New Processing Method of Codonopsis pilosula on Endocrine Physique Index in Rats. |
ACTH, AQP1, AQP2, cGMP, COR, CP, ELISA |
| 59 |
2022 |
The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex. |
CaMKII, CRE, DOI, MAP, pCREB |
| 60 |
2022 |
The Novel microRNA Rno-miR-686-3p Is Associated with the Ischaemic Penumbra. |
miRNA, pMCAO |
| 61 |
2022 |
The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells. |
EPACs, GPCRs |
| 62 |
2022 |
Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease. |
AD, cGMP, PDEs |
| 63 |
2022 |
TLR4/NF-κB/TNFα and cAMP/SIRT1 signaling cascade involved in mediating the dose-dependent effect of cilostazol in ovarian ischemia reperfusion-induced injury. |
CLZ, MDA, NF-kappaB, OIR, PDE, SIRT1, TAC, TLR4, TNF-alpha |
| 64 |
2022 |
Toxic mechanisms of the trichothecenes T-2 toxin and deoxynivalenol on protein synthesis. |
DON, HO, Nrf2, PKA, Wnt |
| 65 |
2022 |
Tramadol Treatment Induces Change in Phospho-Cyclic Adenosine Monophosphate Response Element-Binding Protein and Delta and Mu Opioid Receptors within Hippocampus and Amygdala Areas of Rat Brain. |
AL, ANOVA, CREB, delta-OR, HPC, OR |
| 66 |
2021 |
"ADPKD-omics": determinants of cyclic AMP levels in renal epithelial cells. |
--- |
| 67 |
2021 |
5-HT7 Receptor Is Involved in Electroacupuncture Inhibition of Chronic Pain in the Spinal Cord. |
AC, EA, Gs, KOA, PKA |
| 68 |
2021 |
A genetic basis for friendship? Homophily for membrane-associated PDE11A-cAMP-CREB signaling in CA1 of hippocampus dictates mutual social preference in male and female mice. |
KO, PDE11A4, WT |
| 69 |
2021 |
A most versatile kinase: The catalytic subunit of PKA in T-cell biology. |
PKA |
| 70 |
2021 |
A permeable on-chip microvasculature for assessing the transport of macromolecules and polymeric nanoconstructs. |
DPN |
| 71 |
2021 |
A sub-population of Dictyostelium discoideum cells shows extremely high sensitivity to cAMP for directional migration. |
--- |
| 72 |
2021 |
A tandem motif-based and structural approach can identify hidden functional phosphodiesterases. |
AC, cNMPs, PDEs, SPR |
| 73 |
2021 |
A2A Receptor Dysregulation in Dystonia DYT1 Knock-Out Mice. |
ChAT |
| 74 |
2021 |
Abnormal Calcium Handling in Atrial Fibrillation Is Linked to Changes in Cyclic AMP Dependent Signaling. |
AF, FRET, ISO, PKA, SR |
| 75 |
2021 |
Acrylamide treatment alters the level of Ca2+ and Ca2+-related protein kinase in spinal cords of rats. |
ACR, CaM, CaMKII, Cdk5, PKA, PKC |
| 76 |
2021 |
Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus. |
AKAPs, AQP2, NDI, PKA, V2R |
| 77 |
2021 |
Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway. |
DMPX, MAPK, pCREB, PDRN |
| 78 |
2021 |
Adenylyl cyclase 3 deficiency results in dysfunction of blood-testis barrier during mouse spermiogenesis. |
BTB, DEPs, ESs, LFQ, TJs |
| 79 |
2021 |
Adenylyl cyclase 3 regulates osteocyte mechanotransduction and primary cilium. |
AC |
| 80 |
2021 |
Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates. |
AD, DLPFC, RyRs |
| 81 |
2021 |
AKAP13 couples GPCR signaling to mTORC1 inhibition. |
AKAP13, GPCR, mTORC1, PKA |
| 82 |
2021 |
Alcohol inhibits alveolar fluid clearance through the epithelial sodium channel via the A2 adenosine receptor in acute lung injury. |
AFC, AR, ATII, ENaC, LPS, si |
| 83 |
2021 |
Alterations in cyclic nucleotide signaling are implicated in healthy aging and age-related pathologies of the brain. |
cGMP |
| 84 |
2021 |
An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease. |
ADCY5, ATP, MSNs |
| 85 |
2021 |
Analysis of genome-wide DNA methylation patterns in obesity. |
CRTC1, HOXA9, INHBB, ROC, RT-qPCR, TNNT3, ZBTB7B |
| 86 |
2021 |
Anterior thalamic nuclei deep brain stimulation inhibits mossy fiber sprouting via 3',5'-cyclic adenosine monophosphate/protein kinase A signaling pathway in a chronic epileptic monkey model. |
ATN, DBS, EP, KA, MFS, PKA |
| 87 |
2021 |
Anti-melanogenic property of ginsenoside Rf from Panax ginseng via inhibition of CREB/MITF pathway in melanocytes and ex vivo human skin. |
CRTC3, FSK, MITF, PKA |
| 88 |
2021 |
Antiallodynic action of phosphodiesterase inhibitors in a mouse model of peripheral nerve injury. |
cGMP, PBMCs, PDE, PDEi, TNF-alpha |
| 89 |
2021 |
Antimelanogenesis Effects of Theasinensin A. |
alpha-MSH, EGCG, ELISA, MC1R, MITF, NHEMs, PKA, RT-PCR, TSA, Tyr, TYRP1 |
| 90 |
2021 |
Antimony-induced astrocyte activation via mitogen-activated protein kinase activation-dependent CREB phosphorylation. |
ERK, GFAP, iNOS, p38 MAPK |
| 91 |
2021 |
Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease. |
cGMP, GABA, L-DOPA, MSNs, PD, PDE10A |
| 92 |
2021 |
Arecoline Enhances Phosphodiesterase 4A Activity to Promote Transforming Growth Factor-beta-Induced Buccal Mucosal Fibroblast Activation via cAMP-Epac1 Signaling Pathway. |
alpha-SMA, BMF, Col1a1, Epac1, OSF, PDE4A, PKA, TGF-beta |
| 93 |
2021 |
Aromatin D-J: Seven previously undescribed labdane diterpenoids isolated from Blumea aromatica. |
ECD, LADs |
| 94 |
2021 |
Assessing the Association of Mitochondrial Function and Inflammasome Activation in Murine Macrophages Exposed to Select Mitotoxic Tri-Organotin Compounds. |
IL, LPS, miRNA, NOD, ROS, TMTOH, TPTOH |
| 95 |
2021 |
Behavioral and Neurochemical Changes in Rats with Recurrent Depression induced by chronic unpredictable stress. |
ACTH, BDNF, CORT, CREB, DG |
| 96 |
2021 |
beta2-adrenergic receptor affinity chromatography with an interaction force analysis model: A method for analysis of active compounds targeting beta2-adrenergic receptor. |
beta2AR, SEM |
| 97 |
2021 |
Biased agonists with less glucagon-like peptide-1 receptor-mediated endocytosis prolong hypoglycaemic effects. |
GLP-1, IPGTT |
| 98 |
2021 |
Bicarbonate, carbon dioxide and pH sensing via mammalian bicarbonate-regulated soluble adenylyl cyclase. |
CAs |
| 99 |
2021 |
Bile Acid Toxicity and Protein Kinases. |
Bax, Bcl-2, BH3, DISC, FADD, IL-1beta, MAPK, MLKL, NADPH, PI3K, RIP1, ROS |
| 100 |
2021 |
Bioavailability of Organic Phosphorus Compounds to the Harmful Dinoflagellate Karenia mikimotoi. |
APase, ATP, PDEase, R5P |
|
A Search Service for Abbreviation / Long Form
